Min-Xia Lu1, Yan-Yun Zhang1, Jun-Fang Jiang2, Yang Ju1, Qing Wu1, Xin Zhao1, Xiao-Hua Wang1. 1. Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou 215006. 2. Department of Cardiothoracic Surgery, The First People's Hospital of Changzhou, Changzhou 213000, China.
Abstract
BACKGROUND: Daily weight monitoring is frequently recommended as a part of heart failure self-management to prevent exacerbations. This study is to identify factors that influence weight monitoring compliance of congestive heart failure patients at baseline and after a 1-year weight management (WM) program. METHODS: This was a secondary analysis of an investigative study and a randomized controlled study. A general information questionnaire assessed patient demographics and clinical variables such as medicine use and diagnoses, and the weight management scale evaluated their WM abilities. Good and poor compliance based on abnormal weight gain from the European Society of Cardiology (> 2 kg in 3 days) were compared, and hierarchical multiple logistic regression analysis was used to identify factors influencing weight monitoring compliance. RESULTS:A total of 316 patients were enrolled at baseline, and 66 patients were enrolled after the 1-year WM program. Of them, 12.66% and 60.61% had good weight monitoring compliance at baseline and after 1 year of WM, respectively. A high WM-related belief score indicated good weight monitoring compliance at both time points [odds ratio (OR), 1.043, 95% confidence interval (CI), 1.023-1.063, p < 0.001; and OR, 2.054, 95% CI, 1.209-3.487, p < 0.001, respectively). Patients with a high WM-related practice score had good weight monitoring compliance at baseline (OR, 1.046, 95% CI, 1.027-1.065, p < 0.001), and patients who had not monitored abnormal weight had poor weight monitoring compliance after the 1-year WM program (OR, 0.244, 95% CI, 0.006-0.991, p = 0.049). CONCLUSIONS: Data from this study suggested that belief related to WM plays an important role in weight monitoring compliance.
RCT Entities:
BACKGROUND: Daily weight monitoring is frequently recommended as a part of heart failure self-management to prevent exacerbations. This study is to identify factors that influence weight monitoring compliance of congestive heart failurepatients at baseline and after a 1-year weight management (WM) program. METHODS: This was a secondary analysis of an investigative study and a randomized controlled study. A general information questionnaire assessed patient demographics and clinical variables such as medicine use and diagnoses, and the weight management scale evaluated their WM abilities. Good and poor compliance based on abnormal weight gain from the European Society of Cardiology (> 2 kg in 3 days) were compared, and hierarchical multiple logistic regression analysis was used to identify factors influencing weight monitoring compliance. RESULTS: A total of 316 patients were enrolled at baseline, and 66 patients were enrolled after the 1-year WM program. Of them, 12.66% and 60.61% had good weight monitoring compliance at baseline and after 1 year of WM, respectively. A high WM-related belief score indicated good weight monitoring compliance at both time points [odds ratio (OR), 1.043, 95% confidence interval (CI), 1.023-1.063, p < 0.001; and OR, 2.054, 95% CI, 1.209-3.487, p < 0.001, respectively). Patients with a high WM-related practice score had good weight monitoring compliance at baseline (OR, 1.046, 95% CI, 1.027-1.065, p < 0.001), and patients who had not monitored abnormal weight had poor weight monitoring compliance after the 1-year WM program (OR, 0.244, 95% CI, 0.006-0.991, p = 0.049). CONCLUSIONS: Data from this study suggested that belief related to WM plays an important role in weight monitoring compliance.
Authors: M F Piepoli; G Q Villani; D Aschieri; S Bennati; F Groppi; M S Pisati; A Rosi; A Capucci Journal: Int J Cardiol Date: 2005-10-26 Impact factor: 4.164
Authors: Maurice M W Nieuwenhuis; Tiny Jaarsma; Dirk J van Veldhuisen; Douwe Postmus; Martje H L van der Wal Journal: Am J Cardiol Date: 2012-04-18 Impact factor: 2.778
Authors: Catharine Morgan; John McBeth; Lis Cordingley; Kath Watson; Kimme L Hyrich; Deborah P M Symmons; Ian N Bruce Journal: Rheumatology (Oxford) Date: 2015-05-13 Impact factor: 7.580